Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.13
-0.01 (-0.19%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $231.38 million as of April 25, 2025. Its market cap has decreased by -52.40% in one year.
Market Cap
231.38M
Enterprise Value
-50.47M
1-Year Change
-52.40%
Ranking
Category
Stock Price
$5.13
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $231.38M, a decrease of -64.82%. That is a compound annual growth rate of -32.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 231.83M | -50.00% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |